The FDA approved several medications in May including the following: Infigratinib, a kinase inhibitor for adults with previously treated, unresectable...
Home
Several molecules and indications were approved in April 2021 by FDA. Among the key approvals are the following: Accelerated approval...
Five new indications/molecules were approved by FDA in March 2021 including the following: Idecabtagene vicleucel for the treatment of adult...
What is Wilson's disease? Wilson's disease is a rare genetic autosomal disease. It occurs in approximately one in 30,000 to 40,000...
What is Alport syndrome? Alport syndrome is one of the rare genetic diseases that affect the kidney and may lead...
Kipuwex is an easily attachable, lightweight IoMT device that wirelessly and continuously measures a plurality of clinically relevant biomarkers vital...
Six new indications/molecules were approved by FDA in February 2021 including the following: Melphalan flufenamide in combination with dexamethasone for adult...
What is Alzheimer's disease? Alzheimer's is an irreversible neurodegenerative disease that usually starts slowly and gradually worsens over time. The exact cause of...
In January 2021, the FDA approved the following new indications/Molecules. Combination of nivolumab and cabozantinib as first-line treatment for patients...
What is Amyloidosis? An amyloidosis is a group of serious and rare diseases in which abnormal proteins, known as amyloid...
